Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.

Oncotarget · 2016 · PMC5363559 · PMID 27764775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

Even though there was a small trend towards diminished extravasation of cancer cells to the lung in the CSMD1 group, this cannot explain the drastic difference in the occurrence of metastatic foci observed in the previous experiment.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.